Abstract
A 25 year old women presented an incidental adrenal mass which was diagnosed to be a pheochromocytoma before surgery by means of a positive 131-l-MIBG scintigraphy. Urinary vanilmandelic acid resulted repeatedly normal as well as basal plasma norepinephrine (NE), epinephrine (E) and dopamine (DA). Urinary homovannilic acid resulted in the normal range. Stimulation tests with iv glucagone, tyramine and metoclopramide evoked normal NE and E responses while a slight increase in plasma DA was observed after metoclopramide. Oral Clonidine suppressed plasma catecholamines (CA) normally. Histologic and immunohistochemical studies confirmed that the tumor was a pheochromocytoma showing positivity for tyrosine hydroxylase but not for dopamine-ß-hydroxylase activity. This case is the first report on a completely asymptomatic pheochromocytoma presenting as an incidental adrenal mass which was investigated with repeated biochemical tests before surgery and demonstrates that, among the extremely variable functional attitudes of pheochromocytomas, a defect in CA synthesis and secretion is also to be included.
Similar content being viewed by others
References
Manger W.M., Gifford R.W. Pheochromocytoma. Springer-Verlag, New York, 1977, p. 1.
Sever P.S., Roberts J.C., Snell M.E. Phaeochromocytoma. Clin. Endocrinol. Metab. 9: 543, 1980.
Cryer P.E. Pheochromocytoma. Clin. Endocrinol. Metab. 14: 203, 1985.
Krane N.K. Clinically unsuspected pheochromocytomas. Arch. Intern. Med. 146: 54, 1986.
Levitt R.G., Stanley R.J., Dehner L.P. Angiography of a clinically nonfunctioning pheochromocytoma. JAMA 233: 268, 1975.
Leong C.H., Wong K.K., Saw D. Asymptomatic phaeochromocytoma of the bladder co-existing with carcinoma. Br. J. Urol. 48: 123, 1976.
Beckmann C.F., Levin DC., Phillips D.A. Angiography of nonfunctioning pheochromocytomas of the adrenal gland. Radiology 124: 53, 1977.
Jones R.F., Rudd T.G., Ricketts H.J., Kiviat M.D., Patterson S.D. Giant abdominal mass in a patient with an 18-year surgical cure of liposarcoma of the lower extremity. J. Urol. 123: 934, 1980.
Lie J.T., Olney B.A., Spitteil J.A. Perioperative hypertensive crisis and hemorrhagic diathesis: fatal complication of clinically unsuspected pheochromocytoma. Am. Heart. J. 100: 716, 1980.
St. John Sutton M.G., Sheps S.G., Lie J.T. Prevalence of clinically unsuspected pheochromocytoma. Mayo Clin. Proc. 56: 354, 1981.
Matsushita K., Ueno P., Kamijo T., Kanzaki M., Ishibashi A. Case profile: asymptomatic pheochromocytoma of retroperitoneum presenting as large hypovascular mass. Urology 19: 553, 1982.
Simpson E.T., Marszalek W.W., Ramsaroop R. Nonfunctioning pheochromocytoma. Urology 25: 632, 1985.
Binder S.R., Sivorinovsky G. Measurement of urinary vanilmandelic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection following extraction by ion-exchange and ion-moderated partition. J. Chromatography 336: 173, 1984.
Neri-Serneri G.G., Masotti G., Gensini G.F., Poggesi L, Abbate R., Mannelli M. Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation? Cardiovasc. Res. 15: 287, 1981.
Grimelius L, Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest. Cell Pathol. 3: 3, 1980.
Taubman I., Pearson O.H., Anton A.H. An asymptomatic catecholamine-secreting pheochromocytoma. Am. J. Med. 57: 953, 1974.
Cross D.A., Meyer J.S. Postoperative deaths due to unsuspected pheochromocytoma. South. Med. J. 70: 1320, 1977.
Ho A.D., Feurle G., Gless K.H., Brandeis W.E. Normotensive familial phaeochromocytoma with predominant noradrenaline secretion. Br. Med. J. 1: 81, 1978.
Cooper M.E., Goodman D., Frauman A., Jerums G., Louis W. Phaeochromocytoma in the elderly: a poorly recognised entity? Br. Med. J. 293: 1474, 1986.
Levey G.S., Wiess S.R., Ruiz E. Characterization of the glucagon receptor in a pheochromocytoma. J. Clin. Endocrinol. Metab. 40: 720, 1975.
Mannelli M., Pupilli C, Lanzillotti R., Ianni L., Amenta F., Ricci A., Serio M. Dopamine modulation of pathologic human chromaffin tissue. Am. J. Hypertens. 3: 22S, 1990.
Mannelli M., De Feo M.L., Maggi M., Pupilli C, Opocher G., Valenza T., Baldi E., Serio M. Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. J. Endocrinol. Invest. 10: 377, 1987.
Mannelli M., Pupilli C, Forti G. Dopamine and pheochromocytomas. In: Amenta F. (Ed.), Dopamine Pathophysiology. CRC Press, Boca Raton, 1990, p. 203.
Tippet P.A., West R.S., McEwan A.J., Middleton J.E., Ackery D.M. A comparison of dopamine and homovannilic acid excretion as prognostic indicators in malignant phaeochromocytoma. Clin. Chim. Acta 166: 123, 1987.
Proye C, Fossati P., Fontaine P., Lefebre J., Decoulx M., Wemeau J.L., Dewailly D., Rwamasirabo E., Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytoma according to their type of secretion. Surgery 34: 389, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mannelli, M., Pupilli, C., Lanzillotti, R. et al. A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. J Endocrinol Invest 16, 817–822 (1993). https://doi.org/10.1007/BF03348933
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348933